Novartis Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-03 11:23:34 ET
More on Novartis
- Novartis: Upside Increasingly Capped, 2026 Will Be A Transition Year (Rating Downgrade)
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- SA analyst upgrades/downgrades: GM, UBER, UNH, NVS
- Healthcare debate should focus on out-of-pocket costs, not list prices – Novartis CEO
Read the full article on Seeking Alpha
For further details see:
Novartis Q4 2025 Earnings Preview
Novartis AG
NASDAQ: NVS
NVS Trading
-0.32% G/L:
$154.04 Last:
978,559 Volume:
$154.69 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
February 22, 2026 03:07:00 pm
Novartis: This Big Pharma Giant Could Be a Sleep?at?Night Core Holding for Decades
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
